Shares of Evofem Biosciences, Inc. (NASDAQ:EVFM – Get Free Report) passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.01 and traded as low as $0.01. Evofem Biosciences shares last traded at $0.01, with a volume of 363,192 shares traded.
Evofem Biosciences Stock Performance
The company has a 50 day moving average of $0.01 and a two-hundred day moving average of $0.01.
About Evofem Biosciences
Evofem Biosciences, Inc, a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100 for the prevention of chlamydia and gonorrhea in Women, and EVO200 for the prevention of recurrent bacterial vaginosis.
Featured Stories
- Five stocks we like better than Evofem Biosciences
- Investing In Automotive Stocks
- Symbotic Shares Down 37%—Is It Time for Bravery or Caution?
- Industrial Products Stocks Investing
- High-Yield Healthcare: 3 Stocks With Strong Dividends
- How to Start Investing in Real Estate
- Beyond the Bargain Bin: 3 Stocks Leading Discount Retail
Receive News & Ratings for Evofem Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evofem Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
